Skip to main content

Table 1 Baseline characteristics of hip fracture among young adults in Taiwan

From: Incidence and excess mortality of hip fracture in young adults: a nationwide population-based cohort study

  

Total

N = 4,523

Male

N = 3,439

Female

N = 1,084

P a

Age, mean ± SD (years)

 

31.03 ± 5.93

31.19 ± 5.85

30.53 ± 6.17

<0.0001

Year, N (%)

2001

585 (12.93)

430 (12.50)

155 (14.30)

0.0344

 

2002

553 (12.23)

415 (12.07)

138 (12.73)

 
 

2003

551 (12.18)

433 (12.59)

118 (10.89)

 
 

2004

589 (13.02)

456 (13.26)

133 (12.27)

 
 

2005

611 (13.51)

462 (13.43)

149 (13.75)

 
 

2006

563 (12.45)

438 (12.74)

125 (11.53)

 
 

2007

537 (11.87)

383 (11.14)

154 (14.21)

 
 

2008

534 (11.81)

422 (12.27)

112 (10.33)

 

Hip fracture, N (%)

Trochanteric

1931 (42.69)

1580 (45.94)

351 (32.38)

<0.0001

 

Cervical

2592 (57.31)

1859 (54.06)

733 (67.62)

 

Operation, N (%)

Internal fixation

4363 (96.46)

3313 (96.34)

1050 (96.86)

0.4125

 

Hemiarthroplasty

160 (3.54)

126 (3.66)

34 (3.14)

 

Charlson score, N (%)

0

4110 (90.87)

3103 (90.23)

1007 (92.9)

0.0267

 

1

267 (5.90)

219 (6.37)

48 (4.43)

 
 

≥2

146 (3.23)

117 (3.40)

29 (2.68)

 

Any comorbidity, N (%)

     
 

Hypertension

116 (2.56)

102 (2.96)

14 (1.28)

0.0024

 

Diabetes mellitus

102 (2.26)

85 (2.48)

17 (1.56)

0.0807

 

Heart disease

50 (1.11)

38 (1.11)

12 (1.10)

0.9955

 

Chronic pulmonary disease

58 (1.28)

47 (1.37)

11 (1.01)

0.3692

 

Chronic liver disease

181 (4.00)

165 (4.81)

15 (1.37)

<.0001

 

Chronic renal disease

45 (1.00)

30 (0.88)

15 (1.37)

0.1390

 

Cerebrovascular disease

44 (0.98)

34 (1.00)

10 (0.92)

0.0807

 

Cancer

102 (2.26)

57 (1.65)

46 (4.22)

<.0001

  1. aThe P value were calculated based on t test or Chi-squared test, which was used to assess the gender difference